A nice counter-trade The latest gathering of the world’s political and business elite, plus the usual smattering of celebrities, is taking place this week...
This article was written by Follow A leading global provider of benchmarks, analytics, and data solutions with multi-asset capabilities FTSE Russell’s solutions offer a...
This article was written by Follow Small deep value individual investor, with a modest private investment portfolio, split approx. 50%-50% between shares and call...
Using a digital advertising strategy is now largely the default option for most organizations, outside of a few very niche markets. The benefits offered...
Sarepta Therapeutics (NASDAQ:SRPT) is a large (~$14 billion market cap) biopharmaceutical company that markets 3 RNA-targeted products for Duchenne muscular dystrophy (DMD) patients. In...